Maverick Medical AI

Company Overview

Snapshot

Founded in July 2017 by Yossi Shahak and Michael Brozino, Maverick Medical AI operates with 11–50 employees. The company has raised $10.4 million across 5 funding rounds from 10 investors, with LionBird participating as a lead investor.

Business overview

Maverick Medical AI is a commercial-stage company specializing in a multi-specialty platform that leverages advanced artificial intelligence and deep-learning technology to autonomously code unstructured patient reports for reimbursement claims. Its core product, mCoder, converts patient charts into medical codes without human coder involvement, aiming to enhance efficiency, accuracy, and capacity in the healthcare revenue cycle. The company serves the healthcare industry, particularly healthcare providers and insurance companies, by addressing challenges in medical coding through its AI-driven solutions.

Strategic signal

This investment suggests a market belief in the company's AI platform for real-time autonomous medical coding and its ability to drive efficiency in revenue cycle management, positioning Maverick Medical AI for further expansion and technological advancement.

Company Intelligence Q&A

What is Maverick Medical AI's primary offering?

Maverick Medical AI offers mCoder, an AI-based platform that uses advanced artificial intelligence and deep-learning technology to autonomously code unstructured patient reports for reimbursement claims, improving efficiency and accuracy in the healthcare revenue cycle.

When was Maverick Medical AI founded and by whom?

Maverick Medical AI was founded in July 2017 by Yossi Shahak and Michael Brozino.

What significant funding event occurred in August 2025?

This investment is aimed at accelerating the development of its mCoder artificial intelligence platform for additional clinical domains.

What was the outcome of the seed investment round in March 2022?

In March 2022, Maverick Medical AI closed a $5 million seed investment round from investors including LionBird. This funding was intended to scale the company's R&D and sales teams and expand its solution for a wider range of clinical domains.

What was a key development for Maverick Medical AI in November 2021?

In November 2021, Maverick Medical AI began rolling out its mCoder deep learning AI platform in the US healthcare market. The platform demonstrated a 95% accuracy rate in automating coding by converting unstructured text in patient charts to medical codes, aiming to increase reimbursement billing and revenues for providers.